PARP Inhibitors in the Treatment of Ovarian Cancer
Introduction Ovarian cancer is a leading cause of cancer mortality globally due to late-stage diagnosis and limited treatment options. PARP inhibitors have shown promise as effective treatments for recurrent and various stages of ovarian cancer. Aim of the Study This study reviews the eff...
Saved in:
Main Authors: | Andrzej Paweł Zuzak, Magdalena Cieślik-Porębska, Krzysztof Kułak, Jagoda Niewiadomska |
---|---|
Format: | Article |
Language: | English |
Published: |
Kazimierz Wielki University
2025-02-01
|
Series: | Journal of Education, Health and Sport |
Subjects: | |
Online Access: | https://apcz.umk.pl/JEHS/article/view/57677 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Ovarian cancer targeted medication: PARP inhibitors, anti-angiogenic drugs, immunotherapy, and more, volume II
by: Zhi-Bin Wang, et al.
Published: (2025-02-01) -
Jejunal Fistula Complicating Ovarian Serous Carcinoma: Case Report of a Rare Phenomenon and Review of the Literature
by: Isin Ureyen, et al.
Published: (2021-08-01) -
Primary Pelvic Tuberculosis That Mimics Ovarian Cancer: A Case Report
by: Özlem Seçilmiş Kerimoğlu, et al.
Published: (2013-04-01) -
Cannabidiol attenuates lipid metabolism and induces CB1 receptor-mediated ER stress associated apoptosis in ovarian cancer cells
by: Xuanhe Fu, et al.
Published: (2025-02-01) -
Pre-injection of exosomes can significantly suppress ovarian cancer growth by activating the immune system in mice
by: Yuanyuan Wang, et al.
Published: (2025-02-01)